$27.3B
$1.84 Million
0.01% of portfolio
16,848
Q1 2025
Reduced 25.75%
$16.6B
$1.41 Million
0.01% of portfolio
6,313
Q1 2025
Reduced 9.49%
$27.1B
$2.2 Million
0.01% of portfolio
26,717
Q1 2025
Reduced 15.21%
$22.3B
$813,000
0.01% of portfolio
6,025
Q1 2025
New
$26.5B
$1.82 Million
0.01% of portfolio
9,894
Q1 2025
Reduced 10.36%
$21.4B
$2.31 Million
0.01% of portfolio
43,195
Q1 2025
Added 2.63%
$38.4B
$786,000
0.01% of portfolio
20,354
Q1 2025
Reduced 19.06%
$19.1B
$1.09 Million
0.01% of portfolio
5,514
Q1 2025
Reduced 15.42%
$6.35B
$2.13 Million
0.01% of portfolio
27,688
Q1 2025
New
$64.2B
$2.19 Million
0.01% of portfolio
5,943
Q1 2025
Reduced 9.28%
$6.36B
$1.42 Million
0.01% of portfolio
16,138
Q1 2025
Reduced 52.28%
$20.7B
$970,000
0.01% of portfolio
14,711
Q1 2025
Reduced 20.66%
$21.3B
$996,000
0.01% of portfolio
24,648
Q1 2025
Reduced 15.83%
Howard Hughes Holdings Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
Ventas Rlty LTD Partnership
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 32.61%
-
$0
0.0% of portfolio
-
Q1 2025
Added 190.0%
$11.8B
$720,000
0.0% of portfolio
50,701
Q1 2025
Reduced 93.64%
-
$0
0.0% of portfolio
-
Q1 2025
Added 33.04%
$9.95B
$651,000
0.0% of portfolio
58,358
Q1 2025
Reduced 46.82%
$1.65B
$89,000
0.0% of portfolio
12,058
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
New
$8.42B
$545,000
0.0% of portfolio
7,579
Q1 2025
Reduced 57.52%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 51.01%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 10.77%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 38.36%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.66%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.03%
$10.5B
$481,000
0.0% of portfolio
7,838
Q1 2025
New
Annaly Capital Management In
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.22%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 2.45%
$15.8B
$654,000
0.0% of portfolio
214,000
Q1 2025
Reduced 48.31%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 1.1%
$14.7B
$16,000
0.0% of portfolio
200
Q1 2025
Reduced 93.91%
-
$0
0.0% of portfolio
-
Q1 2025
Added 2.17%
-
$0
0.0% of portfolio
-
Q1 2025
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 61.54%
$140B
$563,000
0.0% of portfolio
8,480
Q1 2025
Reduced 77.91%
$21.9B
$276,000
0.0% of portfolio
31,619
Q1 2025
Added 41.69%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 2.08%
-
$0
0.0% of portfolio
-
Q1 2025
New
$19.9B
$380,000
0.0% of portfolio
7,300
Q1 2025
Added 24.96%
-
$0
0.0% of portfolio
-
Q1 2025
Added 13.64%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 59.32%
$29.1B
$615,000
0.0% of portfolio
8,907
Q1 2025
New
$18.6B
$205,000
0.0% of portfolio
28,764
Q1 2025
Added 26.36%
$317B
$361,000
0.0% of portfolio
5,040
Q1 2025
Reduced 16.45%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 90.73%
$21.6B
$279,000
0.0% of portfolio
12,675
Q2 2024
New
$19.9B
$456,000
0.0% of portfolio
13,082
Q1 2025
Reduced 26.08%